VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
Two-Year Outcomes After Everolimus- or Sirolimus-Eluting Stents in ISAR-TEST 4 Trial
1. Two-Year Outcomes After Everolimus- or Sirolimus-Eluting Stents in Patients With Coronary Artery Diseasein the ISAR-TEST 4 Trial Robert A. Byrne, Adnan Kastrati, Klaus Tiroch, Steffen Massberg, Anna Wieczorek, Karl-Ludwig Laugwitz, Stefanie Schulz, Jürgen Pache, Massimiliano Fusaro, Melchior Seyfarth, Albert Schömig, Julinda Mehilli Deutsches Herzzentrum & 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich. Germany
3. Intracoronary Stenting and Angiographic Results:Test Efficacy of 3 Limus-Eluting Stents - 4 2603 patients with de novo lesions Biodegradable polymer DES (BP-DES) n=1299 Permanent polymer DES (PP-DES:Xience & Cypher) n=1304 6-8 month & 2 year FU angiography 24-month clinical follow-up ISAR-TEST 4 Study Algorithm Byrne et al. Eur Heart J 2009
11. While there was a trend towards superior antirestenotic efficacy with Xience EES, specifically-powered studies are needed to evaluate the clinical significance of this findingConclusions